EVIMATE in Healthcare: The Logiq of Innovation Logiq, Inc. Acquires EVIMATE, Heralding a New Era in Medical Device Innovation NEW YORK, NY / ACCESSWIRE / October 8, 2024 / Logiq, Inc. (OTC PINK:LGIQ) ("Logiq" or "the Company") proudly announces the definitive agreement to acquire EVIMATE ("EVIMATE"), a pioneer in medical device innovation. This acquisition, valued at $5 million, marks a significant milestone as Logiq diversifies into the medical device.s sector.
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Logiq, Inc. (OTC Markets:LGIQ) ("Logiq" or "the Company"), today announced the definitive agreement to acquire MedLab Essentials, LLC ("MedLab"), a trailblazer in cell and gene therapy innovation. Logiq will acquire MedLab through a share exchange of newly issued shares of LGIQ for 100% of MedLab's shareholder interests.